Supplemental material
Journal of Medical Economics
Volume 25, 2022 - Issue 1
Vaccines
Cost-effectiveness of 20-valent pneumococcal conjugate vaccine in Denmark compared with PPV23
Jens Olsena Incentive Denmark Aps, Holte, Denmark
https://orcid.org/0000-0002-6847-1736
https://orcid.org/0000-0002-6847-1736, Henrik Schnacka Incentive Denmark Aps, Holte, Denmarkhttps://orcid.org/0000-0002-3138-5607
https://orcid.org/0000-0002-3138-5607, Mette Skovdalb Medical Vaccines, Pfizer Denmark ApS, Ballerup, Denmarkhttps://orcid.org/0000-0002-6642-0345
https://orcid.org/0000-0002-6642-0345, Jeffrey Vietric Patient & Health Impact, Pfizer Inc, Collegeville, PA, USAhttps://orcid.org/0000-0002-5610-3098
https://orcid.org/0000-0002-5610-3098, & Peter Bo Poulsend Health & Value, Pfizer Denmark ApS, Ballerup, DenmarkCorrespondence[email protected]
https://orcid.org/0000-0002-5279-4637
https://orcid.org/0000-0002-5279-4637